Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells.
Dr. Amany Keruakous
Advertisement
Articles by Dr. Amany Keruakous
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma
2
11 Years Living With Stage 4 Cancer Inspires Gratitude and Reflection
3
Every FDA Oncology Approval From November 2025
4
Chemo Side Effects for Breast Cancer Led to Weeks in the Hospital
5
